Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-03 Sale |
2021-12-03 6:43 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $53.56 | $535,637 | 207,413 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-02 6:45 pm |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
57,493 | $62.16 | $3,573,658 | 317,284 (Direct) |
View |
| 2021-10-08 Sale |
2021-10-12 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $56.34 | $2,704,536 | 528,105 (Direct) |
View |
| 2021-09-03 Sale |
2021-09-03 5:57 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $60.12 | $601,180 | 217,155 (Direct) |
View |
| 2021-08-27 Sale |
2021-08-27 4:55 pm |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
33,779 | $60.12 | $2,030,864 | 263,340 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-19 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
54,000 | $50.37 | $2,720,182 | 297,119 (Direct) |
View |
| 2021-08-11 Sale |
2021-08-12 10:43 am |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
242,133 | $61 | $14,770,113 | 6,875,698 (Indirect) |
View |
| 2021-08-11 Sale |
2021-08-12 10:42 am |
Kymera Therapeutics Inc. | KYMR | ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
242,133 | $61 | $14,770,113 | 5,763,012 (Indirect Direct) |
View |
| 2021-08-03 Sale |
2021-08-05 4:14 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
6,706 | $60.06 | $402,786 | 606,686 (Direct) |
View |
| 2021-07-29 Sale |
2021-08-02 5:53 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
30,415 | $60.25 | $1,832,371 | 755,683 (Direct) |
View |
| 2021-07-26 Sale |
2021-07-28 4:57 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
12,879 | $60.15 | $774,646 | 683,755 (Direct) |
View |
| 2021-07-08 Sale |
2021-07-09 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $49.7 | $2,385,628 | 578,924 (Direct) |
View |
| 2021-07-01 Purchase |
2021-07-06 6:40 pm |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
544,166 | $47 | $25,575,802 | 268,728 (Indirect Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 4:15 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
23,009 | $51.38 | $1,182,106 | 586,924 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 5:54 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
18,746 | $50.1 | $939,261 | 1,017,175 (Direct) |
View |
| 2021-06-03 Sale |
2021-06-04 4:16 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $46.87 | $468,695 | 227,155 (Direct) |
View |
| 2021-05-12 Sale |
2021-05-14 5:20 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
8,245 | $50.05 | $412,677 | 613,679 (Direct) |
View |
| 2021-04-22 Sale |
2021-04-26 5:15 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
14,407 | $40.23 | $579,619 | 1,077,590 (Direct) |
View |
| 2021-04-15 Sale |
2021-04-19 7:12 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
5,593 | $40.26 | $225,159 | 1,027,540 (Direct) |
View |
| 2021-04-08 Sale |
2021-04-12 6:11 pm |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $33.62 | $1,613,563 | 1,163,702 (Direct) |
View |
| 2021-03-12 Sale |
2021-03-16 7:39 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
229,350 | $56.5 | $12,958,275 | 7,998,317 (Indirect) |
View |
| 2021-03-12 Sale |
2021-03-16 7:37 pm |
Kymera Therapeutics Inc. | KYMR | ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
229,350 | $56.5 | $12,958,275 | 6,885,631 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-03 Exercise |
2021-12-03 6:43 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 207,413 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-03 6:43 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 207,413 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-23 4:59 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 217,155 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-23 4:59 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 217,155 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 6:45 pm |
N/A 2028-10-31 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
39,603 | $0 | 317,284 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 6:45 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
20,000 | $1.31 | 317,284 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 6:45 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
19,603 | $2.08 | 317,284 (Direct) |
View |
| 2021-10-08 Exercise |
2021-10-12 4:30 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $0 | 528,105 (Direct) |
View |
| 2021-10-08 Exercise |
2021-10-12 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $2.08 | 528,105 (Direct) |
View |
| 2021-09-03 Option Award |
2021-09-03 5:57 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 217,155 (Direct) |
View |
| 2021-09-03 Exercise |
2021-09-03 5:57 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 217,155 (Direct) |
View |
| 2021-08-27 Exercise |
2021-08-27 4:55 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
33,779 | $0 | 263,340 (Direct) |
View |
| 2021-08-27 Exercise |
2021-08-27 4:55 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
33,779 | $20 | 263,340 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 4:30 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
54,000 | $0 | 297,119 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer |
54,000 | $20 | 297,119 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-19 4:30 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
12,000 | $0 | 548,623 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-19 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
12,000 | $2.08 | 548,623 (Direct) |
View |
| 2021-08-03 Exercise |
2021-08-05 4:14 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
6,706 | $0 | 606,686 (Direct) |
View |
| 2021-08-03 Exercise |
2021-08-05 4:14 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
6,706 | $2.08 | 606,686 (Direct) |
View |
| 2021-07-29 Exercise |
2021-08-02 5:53 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
30,415 | $0 | 755,683 (Direct) |
View |
| 2021-07-29 Exercise |
2021-08-02 5:53 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
30,415 | $2.08 | 755,683 (Direct) |
View |
| 2021-07-26 Exercise |
2021-07-28 4:57 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
12,879 | $0 | 683,755 (Direct) |
View |
| 2021-07-26 Exercise |
2021-07-28 4:57 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
12,879 | $2.08 | 683,755 (Direct) |
View |
| 2021-07-08 Exercise |
2021-07-09 4:30 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $0 | 578,924 (Direct) |
View |
| 2021-07-08 Exercise |
2021-07-09 4:30 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $2.08 | 578,924 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-21 5:36 pm |
N/A 2031-06-20 |
Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:19 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
20,063 | $0 | 2,617,687 (Indirect) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:51 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Nicholson Donald William Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:50 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:49 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:49 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:48 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Hrustanovic Gorjan Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:47 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:44 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:43 pm |
N/A 2031-06-15 |
Kymera Therapeutics Inc. | KYMR | Hall Steven Edward Director |
20,063 | $0 | 20,063 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-14 5:57 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
40,000 | $0 | 548,623 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-14 5:57 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
40,000 | $2.08 | 548,623 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:15 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
23,009 | $0 | 586,924 (Direct) |
View |
| 2021-06-10 Exercise |
2021-06-11 4:15 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
23,009 | $2.08 | 586,924 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 5:54 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
18,746 | $0 | 1,017,175 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 5:54 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
18,746 | $2.08 | 1,017,175 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 4:16 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 227,155 (Direct) |
View |
| 2021-06-03 Exercise |
2021-06-04 4:16 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 227,155 (Direct) |
View |
| 2021-05-19 Exercise |
2021-05-19 5:56 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
15,000 | $0 | 548,623 (Direct) |
View |
| 2021-05-19 Exercise |
2021-05-19 5:56 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
15,000 | $2.08 | 548,623 (Direct) |
View |
| 2021-05-18 Other |
2021-05-18 6:17 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. 10% Owner |
1,122,619 | $0 | 6,885,631 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 5:20 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
8,245 | $0 | 613,679 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 5:20 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
8,245 | $2.08 | 613,679 (Direct) |
View |
| 2021-04-22 Exercise |
2021-04-26 5:15 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
14,407 | $0 | 1,077,590 (Direct) |
View |
| 2021-04-22 Exercise |
2021-04-26 5:15 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
14,407 | $2.08 | 1,077,590 (Direct) |
View |
| 2021-04-15 Exercise |
2021-04-19 7:12 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
11,593 | $0 | 1,027,540 (Direct) |
View |
| 2021-04-15 Exercise |
2021-04-19 7:12 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
11,593 | $2.08 | 1,027,540 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 6:39 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
15,000 | $0 | 548,623 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 6:39 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
15,000 | $2.08 | 548,623 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 6:37 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
7,000 | $0 | 236,899 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 6:37 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
7,000 | $2.08 | 236,899 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-12 6:11 pm |
N/A 2019-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $0 | 1,163,702 (Direct) |
View |
| 2021-04-08 Exercise |
2021-04-12 6:11 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
48,000 | $2.08 | 1,163,702 (Direct) |
View |